{
  "id": 7936395,
  "title": "Puma biotechnology director Cesano sells shares worth $566,994",
  "url": "https://urgent.news/2026/09/17/puma-biotechnology-director-cesano-sells-shares-worth-566-994",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-09-17T03:00:55.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/insider-trading-news/puma-biotechnology-director-cesano-sells-shares-worth-566994-93CH-4904779"
  },
  "original_language": "en",
  "account": "Alessandra Cesano, a director at Puma Biotechnology, Inc., traded 62,150 shares of the company's stock on September 14, 2026, according to a report. The sale, executed under a pre-approved plan, earned Cesano roughly $566,994. The shares were traded at prices between $9.03 and $9.2. Later in the same day, Cesano used stock options she had been granted to buy 50,000 additional shares, spending $146,500. This brought her total holdings to 56,700 shares of common stock and 50,000 stock options. Despite this insider sale, Puma Biotechnology's stock is currently trading at $9.39, close to its 52-week high of $9.73, after a strong 116% increase over the last year. InvestmentPro analysts suggest the stock is undervalued, with a Fair Value of $11.63, indicating possible future appreciation. The company trades at a P/E ratio of 18.4 and a market capitalization of $485 million. InvestingPro provides 11 additional expert tips for those interested in PBYI. Recently, Puma Biotechnology reported strong second-quarter 2026 results, beating expectations with $56.5 million in revenue and GAAP earnings of $0.16 per diluted share. This marked a return to profitability after a loss in the prior quarter. Revenue grew by 9% year-over-year, driven primarily by increased sales of NERLYNX.",
  "summary": null,
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Investing.com",
        "title": "Puma Biotechnology director Troy Wilson sells $45,500 in stock",
        "url": "https://urgent.news/2026/09/17/puma-biotechnology-director-troy-wilson-sells-45-500-in-stock",
        "published": "2026-09-17T02:49:50.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}